AGIO Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

$56.59  +0.18 (0.32%)
As of 06/24/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/24/2013
Outstanding shares:  61,574,283
Average volume:  519,491
Market cap:   $3,499,882,246
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00847X104
ISIN:        US00847X1046
Sedol:      BCBVTX1
Valuation   (See tab for details)
PE ratio:   2.19
PB ratio:   1.71
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy